Company: EUDAW
Filing Date: 2025-04-29
Form Type: 20-F
Source: 0001641172-25-006627
Chunk: 14

Company: EUDA Health Holdings Ltd
Filing Date: 2025-04-29
Form: 20-F
Item: Item 3
Chunk 14
---
  encourage both new and existing consumers to adopt new offerings;                  
  increase                                                                           
  expand the number of subscription and wellness programs that EUDA manages;         
  improve user engagement and loyalty through personalized wellness plans;           
  enhance customer education and awareness, particularly around innovative           
  comply with current and future laws and regulations affecting the healthcare       
  monitor and adapt to regulatory changes around supplements and alternative         
  manage cross-border compliance for international expansion or distribution         
  anticipate macroeconomic trends that affect consumer behavior and healthcare       
  adapt to pricing changes in stem cell and bioenergy therapies, and supplements;    
  innovate in response to evolving consumer preferences toward preventive            
  react to challenges posed by existing competitors and new market entrants;         
  differentiate through innovation and integrated wellness solutions;                
  maintain and strengthen brand credibility in both medical and wellness             
  proactively manage public perception of stem cell and bioenergy therapies;         
  mitigate reputational risks from misinformation, adverse outcomes, or regulatory   
  scale infrastructure and customer support to meet                                  
  optimize logistics for sensitive product handling (e.g., cold chain for            
  integrate new technology platforms and streamline internal systems.                

Any
failure to address the risks and difficulties that EUDA faces, including those associated with the challenges listed above and elsewhere
in this “ Risk Factors” section, could adversely affect EUDA’s business, financial condition, and results of operations.
If EUDA’s assumptions regarding these risks
and uncertainties, which it uses to plan and operate its business, are incorrect or change, or if EUDA does not address these risks effectively
and efficiently, EUDA’s results of operations could differ materially from its expectations and EUDA’s business, financial
condition and results of operations would be adversely affected.

   9  

The
industry that EUDA operates in is highly competitive and rapidly evolving, and if it is not able to compete effectively, its business,
financial condition and results of operations may be adversely impacted.

EUDA
operates in a highly competitive and rapidly evolving industry, and we expect that competition will increase as a result of consolidation
in the healthcare industry and also from new entrants in the markets in which we operate. The Company’s
future growth and success will depend on its ability to successfully compete with other companies that provide similar services and other
healthcare organizations that seek to build and operate competing services and newer companies that provide similar services at substantially
lower prices.

EUDA
competes on the basis of various factors, including breadth and depth of services, reputation,